MedPath

Evaluation of L-Arginine Supplementation on the Improvement of Uterine Artery Pulsatility Index in Color Doppler Ultrasound in Pregnant Women with Increased Uterine Artery Resistance

Phase 4
Conditions
Increased resistance of the uterine artery in color Doppler ultrasound in pregnant women.
O28.3
028.3
Registration Number
IRCT20180416039335N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

Pregnant women with increased uterine artery resistance, presenting to Talaghani Hospital in Arak, where their elevated uterine artery blood pressure is diagnosed by specialists in obstetrics and gynecology and Doppler ultrasound between weeks 12-24
Consent to participate in the study
Not having a specific diet regimen and not using lipid-lowering or blood sugar-lowering medications
No sensitivity to L-arginine (including any drug allergies to this supplement)

Exclusion Criteria

The patient does not wish to continue cooperation or medication usage, and will not attend for ultrasound or visits
During the study, signs and symptoms of drug hypersensitivity (including any drug allergies to this supplement) to L-arginine may manifest in pregnant women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath